Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Dermatologic 1

Conditions

Sezary Syndrome 1Mycosis Fungoides 1Lymphoma, T-Cell, Cutaneous 1

Interventions

Peripheral Blood Stem Cell Transplantation 28fludarabine phosphate 25Cyclophosphamide 19Cyclosporine 18Whole-Body Irradiation 17Mycophenolic Acid 17Tacrolimus 15Busulfan 13Antilymphocyte Serum 11Methotrexate 10Methylprednisolone 8Filgrastim 8Vorinostat 7Radiotherapy 7Flow Cytometry 7Etoposide 7Bortezomib 6Psychiatric Rehabilitation 5Everolimus 5Dexamethasone 5Bexarotene 5Alemtuzumab 5Transplantation 4Therapeutics 4Polymerase Chain Reaction 4Panobinostat 4Lenalidomide 4Gemcitabine 4Carboplatin 4Calcium Dobesilate 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Sezary Syndrome × SUB1 protein, human × Clear all
NCT01800838 2019-05-16

Silicon Phthalocyanine 4 and Photodynamic Therapy in Stage IA-IIA Cutaneous T-Cell Non-Hodgkin Lymphoma

Case Comprehensive Cancer Center

Phase 1 Completed
11 enrolled 10 charts
DermatologicLymphoid

Mycosis Fungoides, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡